Rohit Varma is an Ophthalmology physician affiliated with University of Southern California. OpenAlex indexes 680 publications with 46,179 citations (h-index 90); ClinicalTrials.gov lists 2 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 1% of Ophthalmology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1300 N Vermont Ave Ste 101
Los Angeles, CA 900276061
Telephone
323-644-4445Provider last certified this registry record 14 Jun 2021.
Clinical trials
- Amblyopia and Strabismus Detection Using a Pediatric Vision Scanner
Sponsor: Rebiscan, Inc.
- Advanced Imaging for Glaucoma Study
Sponsor: Oregon Health and Science University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alcon Vision LLCProgram year20257 payments
- Thea Pharma Inc.Program year20255 payments
- ABBVIE INC.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
90.7%Prostaglandin Analog32.8%Latanoprost90%Lumigan9%Travoprost1%Iyuzeh1%Xalatan0%Part D<11 patientsCarbonic Anhydrase Inhibitor31.1%Simbrinza38%Dorzolamide-Timolol35%Brinzolamide12%Dorzolamide Hcl9%Acetazolamide Er4%Azopt1%Part D<11 patients+ 8 more classes in this area
Cardiovascular
2.9%Beta blocker2.9%Timolol Maleate100%Part D≥81 patientsCancer & immunology
2.6%Calcineurin inhibitor2.6%Restasis51%Cyclosporine38%Restasis Multidose11%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
6 NIH research awards on record, funded 1993–2017 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
David Liebeskind, MD
University of Southern California
Lon Schneider, MD
University of Southern California
Amytis Towfighi, MD
University of Southern California
Norah Terrault, MD
University of Southern California
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”